---
title: "White Lion Capital discloses sale of 210,561 Actelis Networks shares for $14,739.27"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293995840.md"
description: "White Lion Capital, a 10% owner of Actelis Networks (ASNS), sold 210,561 shares between July 23-24 at $0.07 per share, totaling $14,739.27. Consequently, White Lion's direct stake decreased to 2,789,439 shares. The holder also reported warrants for 3.85 million shares at $0.0001 and 3 million shares at $0.20."
datetime: "2026-07-28T01:59:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293995840.md)
  - [en](https://longbridge.com/en/news/293995840.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293995840.md)
---

# White Lion Capital discloses sale of 210,561 Actelis Networks shares for $14,739.27

-   Actelis Networks (ASNS) 10% owner White Lion Capital sold 210,561 shares on July 23-24 at USD 0.07. \* White Lion Capital’s direct stake fell to 2,789,439 shares. \* The holder also reported warrants to buy 3.85 million shares at USD 0.0001 and 3 million shares at USD 0.2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actelis Networks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-318582), on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASNS.US](https://longbridge.com/en/quote/ASNS.US.md)

## Related News & Research

- [Actelis Networks files initial beneficial ownership statement by White Lion Capital LLC](https://longbridge.com/en/news/292543604.md)
- [Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22](https://longbridge.com/en/news/294696340.md)
- [NanoViricides issues warrants exercisable at US$1.75 in US$3.8 million registered direct offering](https://longbridge.com/en/news/294342376.md)
- [Inhibikase swaps 18,030,000 shares for RA Capital pre-funded warrant in unregistered offering](https://longbridge.com/en/news/294255122.md)
- [Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal](https://longbridge.com/en/news/294409414.md)